MENLO PARK, Calif.--(BUSINESS WIRE)--Synthekine Inc., an engineered cytokine therapeutics company, today announced the publication of preclinical data for its lead cell therapy program using the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback